{
  "id": 6315734,
  "title": "MASH may require personalized treatment as distinct disease subtypes emerge",
  "url": "https://urgent.news/2026/09/08/mash-may-require-personalized-treatment-as-distinct-disease-subtypes",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-08T19:20:03.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-mash-require-personalized-treatment-distinct.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, affecting an estimated 38% of adults worldwide. Its progressive form, MASH, is characterized by inflammation and damage to liver cells and can lead to liver cirrhosis and liver cancer, among other complications. MASH is also becoming an increasingly important reason for liver…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}